The Cooper Companies, Inc operates as a medical device company worldwide. It operates through CooperVision and CooperSurgical business units. The company develops, manufactures, and markets a range of contact lenses, including spherical lenses, and toric and multifocal lenses that correct near- and farsightedness, as well as addresses various complex visual defects, such as astigmatism and presbyopia.
Read More…
Industry, Sector and Symbol
Industry Ophthalmic goods
Sub-IndustryHealth Care Supplies
SectorMedical
Phone925-460-3600
Debt
Price-To-Earnings
Sales & Book Value
Annual Sales$2.53 billion
Profitability
Miscellaneous
Employees12,000
Next Earnings Date12/5/2019 (Confirmed)
OptionableOptionable
Cooper Companies (NYSE:COO) Frequently Asked Questions
What is Cooper Companies' stock symbol?
Cooper Companies trades on the New York Stock Exchange (NYSE) under the ticker symbol "COO."
How often does Cooper Companies pay dividends? What is the dividend yield for Cooper Companies?
Cooper Companies announced a Semi-Annual dividend on Wednesday, July 10th. Stockholders of record on Tuesday, July 23rd will be paid a dividend of $0.03 per share on Wednesday, August 7th. The ex-dividend date is Monday, July 22nd. View Cooper Companies' Dividend History.
How were Cooper Companies' earnings last quarter?
Cooper Companies Inc (NYSE:COO) posted its quarterly earnings results on Thursday, August, 30th. The medical device company reported $3.00 earnings per share for the quarter, missing the Zacks' consensus estimate of $3.07 by $0.07. The medical device company had revenue of $660 million for the quarter, compared to analyst estimates of $653.44 million. Cooper Companies had a return on equity of 17.15% and a net margin of 17.08%. View Cooper Companies' Earnings History.
When is Cooper Companies' next earnings date?
What price target have analysts set for COO?
11 brokerages have issued 12 month price targets for Cooper Companies' stock. Their forecasts range from $221.00 to $365.00. On average, they expect Cooper Companies' stock price to reach $325.30 in the next year. This suggests a possible upside of 3.8% from the stock's current price. View Analyst Price Targets for Cooper Companies.
What is the consensus analysts' recommendation for Cooper Companies?
11 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Cooper Companies in the last year. There are currently 1 sell rating, 2 hold ratings and 8 buy ratings for the stock, resulting in a consensus recommendation of "Buy." View Analyst Ratings for Cooper Companies.
Has Cooper Companies been receiving favorable news coverage?
News stories about COO stock have trended somewhat positive recently, InfoTrie Sentiment Analysis reports. The research firm scores the sentiment of media coverage by reviewing more than six thousand blog and news sources. The firm ranks coverage of public companies on a scale of negative five to five, with scores nearest to five being the most favorable. Cooper Companies earned a coverage optimism score of 0.9 on InfoTrie's scale. They also gave news headlines about the medical device company a news buzz of 1.0 out of 10, meaning that recent media coverage is extremely unlikely to have an effect on the company's share price in the near term. View News Stories for Cooper Companies.
Are investors shorting Cooper Companies?
Cooper Companies saw a decrease in short interest in the month of November. As of November 15th, there was short interest totalling 945,600 shares, a decrease of 7.3% from the October 31st total of 1,020,000 shares. Based on an average daily volume of 307,800 shares, the short-interest ratio is presently 3.1 days. Approximately 1.9% of the company's shares are sold short. View Cooper Companies' Current Options Chain.
Who are some of Cooper Companies' key competitors?
Some companies that are related to Cooper Companies include Align Technology (ALGN), DENTSPLY SIRONA (XRAY), West Pharmaceutical Services (WST), Haemonetics (HAE), ICU Medical (ICUI), Neogen (NEOG), Quidel (QDEL), STAAR Surgical (STAA), Merit Medical Systems (MMSI), Atrion (ATRI), Anika Therapeutics (ANIK), Antares Pharma (ATRS), Cerus (CERS), OraSure Technologies (OSUR) and Utah Medical Products (UTMD).
What other stocks do shareholders of Cooper Companies own?
Who are Cooper Companies' key executives?
Cooper Companies' management team includes the folowing people:
- Mr. Albert G. White III, Pres, CEO & Director (Age 49)
- Mr. Brian G. Andrews, Sr. VP, CFO & Treasurer (Age 40)
- Mr. Daniel G. McBride, Exec. VP & COO (Age 55)
- Ms. Holly R. Sheffield, Exec. VP & Chief Strategy Officer (Age 48)
- Dr. Robert D. Auerbach, Pres of Coopersurgical Inc (Age 58)
Who are Cooper Companies' major shareholders?
Cooper Companies' stock is owned by a variety of of institutional and retail investors. Top institutional shareholders include State Street Corp (4.20%), Massachusetts Financial Services Co. MA (4.01%), Generation Investment Management LLP (3.08%), Veritas Asset Management LLP (2.00%), California Public Employees Retirement System (0.80%) and WCM Investment Management LLC (0.75%). Company insiders that own Cooper Companies stock include A Thomas Bender, Agostino Ricupati, Allan E Rubenstein, Brian G Andrews, Carol R Kaufman, Daniel G Mcbride, Gary S Petersmeyer, Jody S Lindell, Michael Kalkstein, Randal Golden, Robert D Auerbach, Robert S Weiss and Stanley Md Zinberg. View Institutional Ownership Trends for Cooper Companies.
Which major investors are selling Cooper Companies stock?
COO stock was sold by a variety of institutional investors in the last quarter, including Generation Investment Management LLP, Findlay Park Partners LLP, Massachusetts Financial Services Co. MA, Public Employees Retirement Association of Colorado, State Street Corp, Sawgrass Asset Management LLC, BB&T Securities LLC and Fisher Asset Management LLC. Company insiders that have sold Cooper Companies company stock in the last year include Agostino Ricupati, Allan E Rubenstein, Brian G Andrews, Daniel G Mcbride, Gary S Petersmeyer, Jody S Lindell, Michael Kalkstein, Randal Golden, Robert D Auerbach, Robert S Weiss and Stanley Md Zinberg. View Insider Buying and Selling for Cooper Companies.
Which major investors are buying Cooper Companies stock?
COO stock was bought by a variety of institutional investors in the last quarter, including Robeco Institutional Asset Management B.V., California Public Employees Retirement System, State of Alaska Department of Revenue, WCM Investment Management LLC, Squarepoint Ops LLC, State of Tennessee Treasury Department, Russell Investments Group Ltd. and Pictet Asset Management Ltd.. View Insider Buying and Selling for Cooper Companies.
How do I buy shares of Cooper Companies?
Shares of COO can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity and Charles Schwab.
What is Cooper Companies' stock price today?
One share of COO stock can currently be purchased for approximately $313.33.
How big of a company is Cooper Companies?
Cooper Companies has a market capitalization of $15.53 billion and generates $2.53 billion in revenue each year. The medical device company earns $139.90 million in net income (profit) each year or $11.50 on an earnings per share basis. Cooper Companies employs 12,000 workers across the globe.View Additional Information About Cooper Companies.
What is Cooper Companies' official website?
How can I contact Cooper Companies?
Cooper Companies' mailing address is 6140 Stoneridge Mall Road Suite 590, PLEASANTON CA, 94588. The medical device company can be reached via phone at 925-460-3600 or via email at [email protected]
MarketBeat Community Rating for Cooper Companies (NYSE COO)
MarketBeat's community ratings are surveys of what our community members think about Cooper Companies and other stocks. Vote "Outperform" if you believe COO will outperform the S&P 500 over the long term. Vote "Underperform" if you believe COO will underperform the S&P 500 over the long term. You may vote once every thirty days.
